Get started
Author

Tasuku Hara

Observed names: TASUKU HARA, Tasuku HARA
Observed institutions: Kyoto Prefectural University of Medicine, Nara City Hospital, Toranomon Hospital, Okinaka Memorial Institute for Medical Research, Fukuchiyama City Hospital, Kyoto Saiseikai Hospital
ORCID: 0000-0002-1751-6201
Observed ORCID: 0000-0002-1751-6201
OpenAlex ID: A5030355600
Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer
2020 · Naoto Iwai, Takashi Okuda, et al. · Scientific Reports · 107
PDF
HOMA‐IR : An independent predictor of advanced liver fibrosis in nondiabetic non‐alcoholic fatty liver disease
2019 · Hideki Fujii, Kento Imajo, et al. · Journal of Gastroenterology and Hepatology · 94
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus
2016 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 91
Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus
2016 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 91
Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease
2014 · Yoshio Sumida, Yoshikazu Yonei, et al. · Hepatology Research · 88
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease
2015 · Yoshio Sumida, Kazuyuki Kanemasa, et al. · Journal of Gastroenterology · 85
Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression
2016 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 83
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma
2019 · AYA TAKAHASHI, MICHIHISA MORIGUCHI, et al. · Anticancer Research · 70
Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in J apanese patients
2014 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 58
Complicated relationships of amino acid substitution in hepatitis C virus core region andIL28Bgenotype influencing hepatocarcinogenesis
2012 · Norio Akuta, Fumitaka Suzuki, et al. · Hepatology · 41
PDF
Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B
2013 · Mio Tanaka, Fumitaka Suzuki, et al. · Journal of Gastroenterology · 38
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2020 · Yoshio Sumida, Masashi Yoneda, et al. · Diagnostics · 34
PDF
Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study
2019 · Naoto Iwai, Takashi Okuda, et al. · PLoS ONE · 33
PDF
Hepatic nucleotide binding oligomerization domain‐like receptors pyrin domain‐containing 3 inflammasomes are associated with the histologic severity of non‐alcoholic fatty liver disease
2017 · Hironori Mitsuyoshi, Kohichiroh Yasui, et al. · Hepatology Research · 32
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease
2017 · Yuya Seko, Kanji Yamaguchi, et al. · Journal of Gastroenterology · 30
Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non‐alcoholic steatohepatitis in Japanese patients
2010 · Yoshio Sumida, Yoshikazu Yonei, et al. · Hepatology Research · 29
Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease
2018 · Naoki Mizuno, Yuya Seko, et al. · Journal of Gastroenterology · 28
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease
2017 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 28
PDF
Association of coronary artery calcification with liver fibrosis in Japanese patients with non‐alcoholic fatty liver disease
2016 · Hiroshi Ishiba, Yoshio Sumida, et al. · Hepatology Research · 28
Emergence of telaprevir‐resistant variants detected by ultra‐deep sequencing after triple therapy in patients infected with HCV genotype 1
2013 · Norio Akuta, Fumitaka Suzuki, et al. · Journal of Medical Virology · 27
Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non‐alcoholic fatty liver disease
2016 · Akira Okajima, Yoshio Sumida, et al. · Hepatology Research · 25
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
2020 · Aya Takahashi, Michihisa Moriguchi, et al. · Cancers · 24
PDF
Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB‐4 index
2018 · Yuya Seko, Michihisa Moriguchi, et al. · Hepatology Research · 23
Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1
2013 · Norio Akuta, Fumitaka Suzuki, et al. · Journal of Clinical Microbiology · 23
PDF
Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma
2012 · Yuya Seko, Kenji Ikeda, et al. · Hepatology Research · 21
Works count: 67
Citation count: 1,506
H-index: 23
I10-index: 37
Year
Topic
Type